Neuroprotective role of fibroblast growth factor‐2 in experimental autoimmune encephalomyelitis
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Summary: The role of fibroblast growth factor‐2 (FGF‐2) in multiple sclerosis and its animal model experimental autoimmune encephalomyelitis is discussed. This study is the first to use FGF‐2−/− mice to further address the involvement of FGF‐2 in the disease process. We demonstrate that immunization with myelin oligodendrocyte glycoprotein peptide 35–55 induces more severe experimental autoimmune encephalomyelitis in FGF‐2−/− mice compared with FGF‐2+/+ mice. The antigen‐specific cytokine response to myelin oligodendrocyte glycoprotein peptide and the degree of central nervous system inflammation was similar in both groups. However, FGF‐2−/− mice displayed increased infiltration of CD8+ T cells and macrophages/microglia. In addition, nerve fibre degeneration and axonal loss were augmented, whereas the extent of remyelination in central nervous system lesions was reduced. FGF‐2 has been associated with the induction of demyelination and the inhibition of myelin production by oligodendrocytes. Our study supports the opposing notion that FGF‐2 can also assert a neuroprotective function. This may be particularly appealing when it comes to targeting the neurodegenerative aspect of multiple sclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
Microglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543
Acute axonal injury in multiple sclerosis: Correlation with demyelination and inflammation
Bitsch, A. (2000) · Brain · doi:10.1093/brain/123.6.1174 · Cited by 898
Graeber, M. B. (2010) · Science · doi:10.1126/science.1190929 · Cited by 608
Endogenous cell repair of chronic demyelination
Armstrong, R. C., Le, T. Q., Flint, N. C., Vana, A. C., & Zhou, Y.-X. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000205142.08716.7e · Cited by 125
Cited by
Fibroblast Growth Factor-2 Signaling in Neurogenesis and Neurodegeneration
Woodbury, M. E., & Ikezu, T. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9501-5 · Cited by 266
“…more severe EAE was induced in FGF2(−/−) mice vs. FGF2(+/+) mice, specifically measured by increased infiltration of macrophages/microglia and CD8+ T-cells, increased nerve fiber degeneration, and decreased remyelination of axons, suggesting a protective role of FGF2 (Rottlaender et al. 2011).”
Dysregulated phosphoinositide 3-kinase signaling in microglia: shaping chronic neuroinflammation
Chu, E., Mychasiuk, R., Hibbs, M. L., & Semple, B. D. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02325-6 · Cited by 152
Kuerten, S., Schickel, A., Kerkloh, C., Recks, M. S., Addicks, K., Ruddle, N. H., & Lehmann, P. V. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1023-3 · Cited by 93
Self-citationTang, M.-M., Lin, W.-J., Pan, Y.-Q., & Li, Y.-C. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00255 · Cited by 73
“In the healthy CNS, microglia have highly ramified morphology with thin processes, which dynamically monitor the neural cell microenvironment for surveillance in efforts to maintain homeostasis (Nimmerjahn et al., 2005).”
ResultInfluentialPlasma Biomarkers Discriminate Clinical Forms of Multiple Sclerosis
Tejera-Alhambra, M., Casrouge, A., de Andrés, C., Seyfferth, A., Ramos-Medina, R., Alonso, B., Vega, J., Fernández-Paredes, L., Albert, M. L., & Sánchez-Ramón, S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0128952 · Cited by 55
“They can act as chemoattractants through the recruitment of autoreactive cells from the periphery to the CNS and induce the secretion of proinflammatory cytokines, which promote the final demyelination and neuronal loss [11, 12].”
BackgroundInfluential
Metadata
- Authors
- Rottlaender, A., Villwock, H., Addicks, K., & Kuerten, S.
- Venue
- Immunology
- Publisher
- Wiley
- Published
- 2011-05-13
- Volume
- 133
- Issue
- 3
- Pages
- 370-378
- ISSN
- 0019-2805 (ISSN-L)
- 1365-2567
- OpenAlex
- W1495522011
- Cited by
- 56
- References
- 5
- FWCI
- 3.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuroprotective role of fibroblast growth factor‐2 in experimental autoimmune encephalomyelitis. https://app.cochat.ai/papers/10.1111/j.1365-2567.2011.03450.x
- The paper
- Rottlaender, A., Villwock, H., Addicks, K., & Kuerten, S. (2011). Neuroprotective role of fibroblast growth factor‐2 in experimental autoimmune encephalomyelitis. Immunology. https://doi.org/10.1111/j.1365-2567.2011.03450.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.